צ׳כיה - צ׳כית - SUKL (Státní ústav pro kontrolu léčiv)

zentiva, k.s., praha array - 13182 valsartan; 728 hydrochlorothiazid - potahovaná tableta - 160mg/12,5mg - valsartan a diuretika

צ׳כיה - צ׳כית - SUKL (Státní ústav pro kontrolu léčiv)

zentiva, k.s., praha array - 13182 valsartan; 728 hydrochlorothiazid - potahovaná tableta - 160mg/25mg - valsartan a diuretika

צ׳כיה - צ׳כית - SUKL (Státní ústav pro kontrolu léčiv)

krka, d.d., novo mesto, novo mesto array - 151 benzydamin-hydrochlorid; 12418 monohydrÁt cetylpyridinium-chloridu - pastilka - 3mg/1mg - benzydamin

צ׳כיה - צ׳כית - SUKL (Státní ústav pro kontrolu léčiv)

krka, d.d., novo mesto, novo mesto array - 151 benzydamin-hydrochlorid; 12418 monohydrÁt cetylpyridinium-chloridu - pastilka - 3mg/1mg - benzydamin

צ׳כיה - צ׳כית - SUKL (Státní ústav pro kontrolu léčiv)

farmak international sp.z.o.o., varšava array - 1848 nafazolin-nitrÁt; 2040 antazolin-mesilÁt - nosní kapky, roztok - 0,25mg/ml+5mg/ml - nafazolin

האיחוד האירופי - צ׳כית - EMA (European Medicines Agency)

intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ndv/ilt) expressing the fusion protein of newcastle disease virus and the glycoproteins gd and gi of infectious laryngotracheitis virus - imunologická léčba - embryonated chicken eggs; chicken - for active immunisation of one-day-old chicks or embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.

האיחוד האירופי - צ׳כית - EMA (European Medicines Agency)

glaxosmithkline biologicals sa - recombinant varicella zoster virus glycoprotein e - herpes zoster - vakcíny - shingrix is indicated for prevention of herpes zoster (hz) and post-herpetic neuralgia (phn), in:adults 50 years of age or older;adults 18 years of age or older at increased risk of hz. použití shingrix by měla být v souladu s oficiálními doporučeními.

האיחוד האירופי - צ׳כית - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease virus, serotype 1, strain rn1250; live recombinant turkey herpesvirus, expressing the vp2 protein of infectious bursal disease virus, strain vhvt013-69 - immunologicals for aves, domestic fowl, avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - kuře - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus), and to prevent mortality, clinical signs and lesions caused by infectious bursal disease (ibd) virus.

האיחוד האירופי - צ׳כית - EMA (European Medicines Agency)

virbac s.a. - recombinant omega interferon of feline origin - immunostimulants, - dogs; cats - dogsreduction of mortality and clinical signs of parvovirosis (enteric form) in dogs from one month of age. catstreatment of cats infected with feline leukaemia virus (felv) and / or feline immunodeficiency virus (fiv), in non-terminal clinical stages, from the age of nine weeks. in a field study conducted, it was observed that there was:a reduction of clinical signs during the symptomatic phase (four months);a reduction of mortality:in anaemic cats, mortality rate of about 60% at four, six, nine and 12 months was reduced by approximately 30% following treatment with interferon;in non-anaemic cats, mortality rate of 50% in cats infected by felv was reduced by 20% following treatment with interferon. in cats infected by fiv, mortality was low (5%) and was not influenced by the treatment.

האיחוד האירופי - צ׳כית - EMA (European Medicines Agency)

janssen-cilag international n.v.    - recombinant adenovirus type 26 (ad26) encoding the glycoprotein (gp) of the ebola virus zaire (zebov) mayinga strain - hemoragická horečka, horečka ebola - vakcíny - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.